The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bronchodilator Market Research Report 2025
Synopsis
The global Bronchodilator market was valued at US$ 31140 million in 2023 and is anticipated to reach US$ 42270 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
North American market for Bronchodilator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bronchodilator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bronchodilator include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi and Theron Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bronchodilator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchodilator.
Report Scope
The Bronchodilator market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bronchodilator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchodilator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Roche
AstraZeneca
Boehringer Ingelheim
Amgen
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
Segment by Type
Short-acting Bronchodilator
Long-acting Bronchodilator
Segment by Application
Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bronchodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bronchodilator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Bronchodilator market was valued at US$ 31140 million in 2023 and is anticipated to reach US$ 42270 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
North American market for Bronchodilator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bronchodilator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bronchodilator include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi and Theron Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bronchodilator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchodilator.
Report Scope
The Bronchodilator market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bronchodilator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchodilator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Roche
AstraZeneca
Boehringer Ingelheim
Amgen
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
Segment by Type
Short-acting Bronchodilator
Long-acting Bronchodilator
Segment by Application
Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bronchodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bronchodilator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bronchodilator Market Overview
1.1 Product Overview and Scope of Bronchodilator
1.2 Bronchodilator Segment by Type
1.2.1 Global Bronchodilator Market Value Comparison by Type (2024-2030)
1.2.2 Short-acting Bronchodilator
1.2.3 Long-acting Bronchodilator
1.3 Bronchodilator Segment by Application
1.3.1 Global Bronchodilator Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Global Bronchodilator Market Size Estimates and Forecasts
1.4.1 Global Bronchodilator Revenue 2019-2030
1.4.2 Global Bronchodilator Sales 2019-2030
1.4.3 Global Bronchodilator Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bronchodilator Market Competition by Manufacturers
2.1 Global Bronchodilator Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bronchodilator Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bronchodilator Average Price by Manufacturers (2019-2024)
2.4 Global Bronchodilator Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bronchodilator, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bronchodilator, Product Type & Application
2.7 Bronchodilator Market Competitive Situation and Trends
2.7.1 Bronchodilator Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bronchodilator Players Market Share by Revenue
2.7.3 Global Bronchodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bronchodilator Retrospective Market Scenario by Region
3.1 Global Bronchodilator Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bronchodilator Global Bronchodilator Sales by Region: 2019-2030
3.2.1 Global Bronchodilator Sales by Region: 2019-2024
3.2.2 Global Bronchodilator Sales by Region: 2025-2030
3.3 Global Bronchodilator Global Bronchodilator Revenue by Region: 2019-2030
3.3.1 Global Bronchodilator Revenue by Region: 2019-2024
3.3.2 Global Bronchodilator Revenue by Region: 2025-2030
3.4 North America Bronchodilator Market Facts & Figures by Country
3.4.1 North America Bronchodilator Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bronchodilator Sales by Country (2019-2030)
3.4.3 North America Bronchodilator Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bronchodilator Market Facts & Figures by Country
3.5.1 Europe Bronchodilator Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bronchodilator Sales by Country (2019-2030)
3.5.3 Europe Bronchodilator Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bronchodilator Market Facts & Figures by Country
3.6.1 Asia Pacific Bronchodilator Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bronchodilator Sales by Country (2019-2030)
3.6.3 Asia Pacific Bronchodilator Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bronchodilator Market Facts & Figures by Country
3.7.1 Latin America Bronchodilator Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bronchodilator Sales by Country (2019-2030)
3.7.3 Latin America Bronchodilator Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bronchodilator Market Facts & Figures by Country
3.8.1 Middle East and Africa Bronchodilator Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bronchodilator Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bronchodilator Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bronchodilator Sales by Type (2019-2030)
4.1.1 Global Bronchodilator Sales by Type (2019-2024)
4.1.2 Global Bronchodilator Sales by Type (2025-2030)
4.1.3 Global Bronchodilator Sales Market Share by Type (2019-2030)
4.2 Global Bronchodilator Revenue by Type (2019-2030)
4.2.1 Global Bronchodilator Revenue by Type (2019-2024)
4.2.2 Global Bronchodilator Revenue by Type (2025-2030)
4.2.3 Global Bronchodilator Revenue Market Share by Type (2019-2030)
4.3 Global Bronchodilator Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bronchodilator Sales by Application (2019-2030)
5.1.1 Global Bronchodilator Sales by Application (2019-2024)
5.1.2 Global Bronchodilator Sales by Application (2025-2030)
5.1.3 Global Bronchodilator Sales Market Share by Application (2019-2030)
5.2 Global Bronchodilator Revenue by Application (2019-2030)
5.2.1 Global Bronchodilator Revenue by Application (2019-2024)
5.2.2 Global Bronchodilator Revenue by Application (2025-2030)
5.2.3 Global Bronchodilator Revenue Market Share by Application (2019-2030)
5.3 Global Bronchodilator Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Bronchodilator Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Bronchodilator Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Bronchodilator Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Bronchodilator Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Bronchodilator Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Kissei Pharmaceutical
6.6.1 Kissei Pharmaceutical Corporation Information
6.6.2 Kissei Pharmaceutical Description and Business Overview
6.6.3 Kissei Pharmaceutical Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kissei Pharmaceutical Bronchodilator Product Portfolio
6.6.5 Kissei Pharmaceutical Recent Developments/Updates
6.7 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mitsubishi Tanabe Pharma Bronchodilator Product Portfolio
6.7.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Bronchodilator Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Theron Pharmaceuticals
6.9.1 Theron Pharmaceuticals Corporation Information
6.9.2 Theron Pharmaceuticals Description and Business Overview
6.9.3 Theron Pharmaceuticals Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Theron Pharmaceuticals Bronchodilator Product Portfolio
6.9.5 Theron Pharmaceuticals Recent Developments/Updates
6.10 Array BioPharma
6.10.1 Array BioPharma Corporation Information
6.10.2 Array BioPharma Description and Business Overview
6.10.3 Array BioPharma Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Array BioPharma Bronchodilator Product Portfolio
6.10.5 Array BioPharma Recent Developments/Updates
6.11 Kyowa Hakko Kirin
6.11.1 Kyowa Hakko Kirin Corporation Information
6.11.2 Kyowa Hakko Kirin Bronchodilator Description and Business Overview
6.11.3 Kyowa Hakko Kirin Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kyowa Hakko Kirin Bronchodilator Product Portfolio
6.11.5 Kyowa Hakko Kirin Recent Developments/Updates
6.12 Verona Pharma
6.12.1 Verona Pharma Corporation Information
6.12.2 Verona Pharma Bronchodilator Description and Business Overview
6.12.3 Verona Pharma Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Verona Pharma Bronchodilator Product Portfolio
6.12.5 Verona Pharma Recent Developments/Updates
6.13 Nycomed Pharma
6.13.1 Nycomed Pharma Corporation Information
6.13.2 Nycomed Pharma Bronchodilator Description and Business Overview
6.13.3 Nycomed Pharma Bronchodilator Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nycomed Pharma Bronchodilator Product Portfolio
6.13.5 Nycomed Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bronchodilator Industry Chain Analysis
7.2 Bronchodilator Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bronchodilator Production Mode & Process
7.4 Bronchodilator Sales and Marketing
7.4.1 Bronchodilator Sales Channels
7.4.2 Bronchodilator Distributors
7.5 Bronchodilator Customers
8 Bronchodilator Market Dynamics
8.1 Bronchodilator Industry Trends
8.2 Bronchodilator Market Drivers
8.3 Bronchodilator Market Challenges
8.4 Bronchodilator Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bronchodilator Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bronchodilator Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bronchodilator Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bronchodilator Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Bronchodilator Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bronchodilator Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bronchodilator Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bronchodilator Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bronchodilator, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bronchodilator, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bronchodilator, Product Type & Application
Table 12. Global Key Manufacturers of Bronchodilator, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bronchodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchodilator as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bronchodilator Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bronchodilator Sales by Region (2019-2024) & (K Doses)
Table 18. Global Bronchodilator Sales Market Share by Region (2019-2024)
Table 19. Global Bronchodilator Sales by Region (2025-2030) & (K Doses)
Table 20. Global Bronchodilator Sales Market Share by Region (2025-2030)
Table 21. Global Bronchodilator Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bronchodilator Revenue Market Share by Region (2019-2024)
Table 23. Global Bronchodilator Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bronchodilator Revenue Market Share by Region (2025-2030)
Table 25. North America Bronchodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bronchodilator Sales by Country (2019-2024) & (K Doses)
Table 27. North America Bronchodilator Sales by Country (2025-2030) & (K Doses)
Table 28. North America Bronchodilator Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bronchodilator Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bronchodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bronchodilator Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Bronchodilator Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Bronchodilator Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bronchodilator Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bronchodilator Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bronchodilator Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Bronchodilator Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Bronchodilator Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bronchodilator Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bronchodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bronchodilator Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Bronchodilator Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Bronchodilator Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bronchodilator Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bronchodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bronchodilator Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Bronchodilator Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Bronchodilator Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bronchodilator Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bronchodilator Sales (K Doses) by Type (2019-2024)
Table 51. Global Bronchodilator Sales (K Doses) by Type (2025-2030)
Table 52. Global Bronchodilator Sales Market Share by Type (2019-2024)
Table 53. Global Bronchodilator Sales Market Share by Type (2025-2030)
Table 54. Global Bronchodilator Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bronchodilator Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bronchodilator Revenue Market Share by Type (2019-2024)
Table 57. Global Bronchodilator Revenue Market Share by Type (2025-2030)
Table 58. Global Bronchodilator Price (USD/Dose) by Type (2019-2024)
Table 59. Global Bronchodilator Price (USD/Dose) by Type (2025-2030)
Table 60. Global Bronchodilator Sales (K Doses) by Application (2019-2024)
Table 61. Global Bronchodilator Sales (K Doses) by Application (2025-2030)
Table 62. Global Bronchodilator Sales Market Share by Application (2019-2024)
Table 63. Global Bronchodilator Sales Market Share by Application (2025-2030)
Table 64. Global Bronchodilator Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bronchodilator Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bronchodilator Revenue Market Share by Application (2019-2024)
Table 67. Global Bronchodilator Revenue Market Share by Application (2025-2030)
Table 68. Global Bronchodilator Price (USD/Dose) by Application (2019-2024)
Table 69. Global Bronchodilator Price (USD/Dose) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Bronchodilator Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Roche Bronchodilator Product
Table 79. Roche Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. AstraZeneca Bronchodilator Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Boehringer Ingelheim Bronchodilator Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Amgen Bronchodilator Product
Table 94. Amgen Recent Developments/Updates
Table 95. Kissei Pharmaceutical Corporation Information
Table 96. Kissei Pharmaceutical Description and Business Overview
Table 97. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Kissei Pharmaceutical Bronchodilator Product
Table 99. Kissei Pharmaceutical Recent Developments/Updates
Table 100. Mitsubishi Tanabe Pharma Corporation Information
Table 101. Mitsubishi Tanabe Pharma Description and Business Overview
Table 102. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Mitsubishi Tanabe Pharma Bronchodilator Product
Table 104. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Sanofi Bronchodilator Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Theron Pharmaceuticals Corporation Information
Table 111. Theron Pharmaceuticals Description and Business Overview
Table 112. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Theron Pharmaceuticals Bronchodilator Product
Table 114. Theron Pharmaceuticals Recent Developments/Updates
Table 115. Array BioPharma Corporation Information
Table 116. Array BioPharma Description and Business Overview
Table 117. Array BioPharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Array BioPharma Bronchodilator Product
Table 119. Array BioPharma Recent Developments/Updates
Table 120. Kyowa Hakko Kirin Corporation Information
Table 121. Kyowa Hakko Kirin Description and Business Overview
Table 122. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. Kyowa Hakko Kirin Bronchodilator Product
Table 124. Kyowa Hakko Kirin Recent Developments/Updates
Table 125. Verona Pharma Corporation Information
Table 126. Verona Pharma Description and Business Overview
Table 127. Verona Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Verona Pharma Bronchodilator Product
Table 129. Verona Pharma Recent Developments/Updates
Table 130. Nycomed Pharma Corporation Information
Table 131. Nycomed Pharma Description and Business Overview
Table 132. Nycomed Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 133. Nycomed Pharma Bronchodilator Product
Table 134. Nycomed Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Bronchodilator Distributors List
Table 138. Bronchodilator Customers List
Table 139. Bronchodilator Market Trends
Table 140. Bronchodilator Market Drivers
Table 141. Bronchodilator Market Challenges
Table 142. Bronchodilator Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bronchodilator
Figure 2. Global Bronchodilator Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bronchodilator Market Share by Type in 2023 & 2030
Figure 4. Short-acting Bronchodilator Product Picture
Figure 5. Long-acting Bronchodilator Product Picture
Figure 6. Global Bronchodilator Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bronchodilator Market Share by Application in 2023 & 2030
Figure 8. Asthma
Figure 9. Chronic Obstructive Pulmonary Disease
Figure 10. Others
Figure 11. Global Bronchodilator Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Bronchodilator Market Size (2019-2030) & (US$ Million)
Figure 13. Global Bronchodilator Sales (2019-2030) & (K Doses)
Figure 14. Global Bronchodilator Average Price (USD/Dose) & (2019-2030)
Figure 15. Bronchodilator Report Years Considered
Figure 16. Bronchodilator Sales Share by Manufacturers in 2023
Figure 17. Global Bronchodilator Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Bronchodilator Players: Market Share by Revenue in 2023
Figure 19. Bronchodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Bronchodilator Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Bronchodilator Sales Market Share by Country (2019-2030)
Figure 22. North America Bronchodilator Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Bronchodilator Sales Market Share by Country (2019-2030)
Figure 26. Europe Bronchodilator Revenue Market Share by Country (2019-2030)
Figure 27. Germany Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bronchodilator Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Bronchodilator Revenue Market Share by Region (2019-2030)
Figure 34. China Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Bronchodilator Sales Market Share by Country (2019-2030)
Figure 45. Latin America Bronchodilator Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Bronchodilator Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Bronchodilator Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Bronchodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Bronchodilator by Type (2019-2030)
Figure 55. Global Revenue Market Share of Bronchodilator by Type (2019-2030)
Figure 56. Global Bronchodilator Price (USD/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Bronchodilator by Application (2019-2030)
Figure 58. Global Revenue Market Share of Bronchodilator by Application (2019-2030)
Figure 59. Global Bronchodilator Price (USD/Dose) by Application (2019-2030)
Figure 60. Bronchodilator Value Chain
Figure 61. Bronchodilator Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
